These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
499 related items for PubMed ID: 19718468
1. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies. Livnat T, Tamarin I, Mor Y, Winckler H, Horowitz Z, Korianski Y, Bar-Zakay B, Seligsohn U, Salomon O. Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468 [Abstract] [Full Text] [Related]
4. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Santagostino E, Morfini M, Rocino A, Baudo F, Scaraggi FA, Gringeri A. Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352 [Abstract] [Full Text] [Related]
5. Factor XI Deficiency. Duga S, Salomon O. Semin Thromb Hemost; 2009 Jun; 35(4):416-25. PubMed ID: 19598070 [Abstract] [Full Text] [Related]
6. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency. O'Connell NM, Riddell AF, Pascoe G, Perry DJ, Lee CA. Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352 [Abstract] [Full Text] [Related]
7. Cataract extraction without prophylactic treatment in patients with severe factor XI deficiency. Fabian ID, Sachs D, Moisseiev J, Alhalel A, Grinbaum A, Seligsohn U, Salomon O. Am J Ophthalmol; 2009 Dec; 148(6):920-4.e1. PubMed ID: 19733832 [Abstract] [Full Text] [Related]
8. Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery. Salomon O, Budnik I, Avishai E, Tamarin I, Bashari D, Dardik R, Livnat T. Thromb Haemost; 2019 Dec; 119(12):1927-1932. PubMed ID: 31493780 [Abstract] [Full Text] [Related]
14. A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency. Bozzao C, Rimoldi V, Asselta R, Landau M, Ghiotto R, Tenchini ML, De Cristofaro R, Castaman G, Duga S. FEBS J; 2007 Dec; 274(23):6128-38. PubMed ID: 17971173 [Abstract] [Full Text] [Related]
15. Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors. Kenet G, Lubetsky A, Luboshitz J, Ravid B, Tamarin I, Varon D, Martinowitz U. Haemophilia; 2009 Sep; 15(5):1065-73. PubMed ID: 19486172 [Abstract] [Full Text] [Related]
16. Perioperative use of modified thrombelastography in factor XI deficiency: a helpful method to assess drug effects. Dirkmann D, Hanke AA, Görlinger K, Peters J. Acta Anaesthesiol Scand; 2007 May; 51(5):640-3. PubMed ID: 17430330 [Abstract] [Full Text] [Related]
17. Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven®, a factor XI concentrate. Santoro C, Goldberg I, Bridey F, Figgie MP, Karila-Israel D, Haviland K, Mackenzie CR, Dimichele DM. Haemophilia; 2011 Sep; 17(5):777-82. PubMed ID: 21699628 [Abstract] [Full Text] [Related]
20. Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis. Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, Seligsohn U. Thromb Haemost; 2011 Feb; 105(2):269-73. PubMed ID: 21057700 [Abstract] [Full Text] [Related] Page: [Next] [New Search]